The genomics market is fragmented in nature with several major players. In terms of market share, a few major players are currently dominating the market. A few prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions across the world. Some companies currently dominating the market are Illumina Inc., Thermo Fisher Scientific, Agilent Technologies, Luminex Corporation, and Myriad Genetics Inc.
Table of Contents 1. Executive Summary 2. Industry Outlook 2.1. Industry Overview 2.2. Industry Trends 3. Market Snapshot 3.1. Market Definition 3.2. Market Outlook 3.2.1. Porter Five Forces 3.3. Related Markets 4. Market characteristics 4.1. Market Overview 4.2. Market Segmentation 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. DRO - Impact Analysis 5. Type: Market Size & Analysis 5.1. Overview 5.2. Products 5.3. Services 6. Technology: Market Size & Analysis 6.1. Overview 6.2. Sequencing 6.3. PCR 6.4. Flow Cytometry 6.5. Microarrays 6.6. Other Technologies (electrophoresis, southern blotting, isothermal nucleic acid amplification, and in situ hybridization) 7. Application: Market Size & Analysis 7.1. Overview 7.2. Drug Discovery and Development 7.3. Diagnostics 7.4. Agriculture and Animal research 7.5. Other Applications (marine research, biofuel research, food industry, and forensics) 8. Study Type: Market Size & Analysis 8.1. Overview 8.2. Functional Genomics 8.3. Biomarker Discovery 8.4. Pathway Analysis 8.5. Epigenomics 8.6. Other Study Types (structural genomics, comparative genomics, and mutation genomics) 9. End-User: Market Size & Analysis 9.1. Overview 9.2. Hospitals and Clinics 9.3. Academic and Research Institutes 9.4. Pharmaceutical & Biotechnology companies 9.5. Other End Users (agrigenomics organizations, marine research organizations, forensic organizations, and food organizations) 10. Geography: Market Size & Analysis 10.1. Overview 10.2. North America (U.S., Mexico, Canada) 10.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe) 10.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC) 10.5. Latin America (Brazil, Argentina) 10.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa) 11. Competitive Landscape 11.1. Competitor Comparison Analysis 11.2. Market Developments 11.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships 11.2.2. Product Launches and execution 12. Vendor Profiles 12.1. Illumina, Inc. (U.S.). 12.1.1. Overview 12.1.2. Financial Overview 12.1.3. Product Offerings 12.1.4. Developments 12.1.5. Business Strategy 12.2. Thermo Fisher Scientific Inc. (U.S.) Inc. 12.2.1. Overview 12.2.2. Financial Overview 12.2.3. Product Offerings 12.2.4. Developments 12.2.5. Business Strategy 12.3. F. Hoffmann-La Roche Ltd. (Switzerland) 12.3.1. Overview 12.3.2. Financial Overview 12.3.3. Product Offerings 12.3.4. Developments 12.3.5. Business Strategy 12.4. Agilent Technologies, Inc. (U.S.) 12.4.1. Overview 12.4.2. Financial Overview 12.4.3. Product Offerings 12.4.4. Developments 12.4.5. Business Strategy 12.5. Drive Oxford Nanopore Technologies (U.K.) 12.5.1. Overview 12.5.2. Financial Overview 12.5.3. Product Offerings 12.5.4. Developments 12.5.5. Business Strategy 12.6. Danaher (U.S.) 12.6.1. Overview 12.6.2. Financial Overview 12.6.3. Product Offerings 12.6.4. Developments 12.6.5. Business Strategy 12.7. QIAGEN (Germany) 12.7.1. Overview 12.7.2. Financial Overview 12.7.3. Product Offerings 12.7.4. Developments 12.7.5. Business Strategy 12.8. BGI (China) 12.8.1. Overview 12.8.2. Financial Overview 12.8.3. Product Offerings 12.8.4. Developments 12.8.5. Business Strategy 12.9. IntegraGen (France) 12.9.1. Overview 12.9.2. Financial Overview 12.9.3. Product Offerings 12.9.4. Developments 12.9.5. Business Strategy 12.10. General Electric Company (U.S.) 12.10.1. Overview 12.10.2. Financial Overview 12.10.3. Product Offerings 12.10.4. Developments 12.10.5. Business Strategy 13. Analyst Opinion 14. Annexure
List of Tables TABLE 1. GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 2. GENOMICS MARKET VALUE FOR PRODUCT AND SERVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 3. GENOMICS MARKET VALUE FOR CONSUMABLES AND REAGENTS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 4. GENOMICS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 5. GENOMICS MARKET VALUE FOR INSTRUMENTS,SYSTEMS AND SOFTWARE, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 6. GENOMICS MARKET VALUE, BY TECHNOLOGY, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 7. GENOMICS MARKET VALUE FOR SEQUENCING, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 8. GENOMICS MARKET VALUE FOR PCR, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 9. GENOMICS MARKET VALUE FOR FLOW CYTOMETRY, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 10. GENOMICS MARKET VALUE FOR MICROARRAYS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 11. GENOMICS MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 12. GENOMICS MARKET VALUE FOR DRUG DISCOVERY AND DEVELOPMENT, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 13. GENOMICS MARKET VALUE FOR DIAGNOSTICS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 14. GENOMICS MARKET VALUE FOR AGRICULTURE AND ANIMAL RESEARCH, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 15. GENOMICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 16. GENOMICS MARKET VALUE, BY STUDY TYPE, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 17. GENOMICS MARKET VALUE FOR FUNCTIONAL GENOMICS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 18. GENOMICS MARKET VALUE FOR BIOMARKER DISCOVERY, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 19. GENOMICS MARKET VALUE FOR PATHWAY ANALYSIS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 20. GENOMICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 21. GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 22. GENOMICS MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 23. GENOMICS MARKET VALUE FOR ACADEMICS AND RESEARCH INSTITUTE, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 24. GENOMICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 25. NORTH AMERICA GENOMICS MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 26. NORTH AMERICA GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 27. NORTH AMERICA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 28. NORTH AMERICA GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 29. U.S GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 30. U.S GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 31. U.S GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 32. CANADA GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 33. CANADA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 34. CANADA GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 35. EUROPE GENOMICS MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 36. EUROPE GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 37. EUROPE GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 38. EUROPE GENOMICS MARKET VALUE, END-USER, 2021-2027 (USD BILLION) TABLE 39. GERMANY GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 40. GERMANY GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 41. GERMANY GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 42. U.K GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 43. U.K GENOMICSMARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 44. U.K GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 45. FRANCE GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 46. FRANCE GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 47. FRANCE GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 48. ITALY GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 49. ITALY GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 50. ITALY GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 51. SPAIN GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 52. SPAIN GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 53. SPAIN GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 54. ROE GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 55. ROE GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 56. ROE GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 57. ASIA PACIFIC GENOMICS MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 58. ASIA PACIFIC GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 59. ASIA PACIFIC GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 60. ASIA PACIFIC GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 61. CHINA GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 62. CHINA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 63. CHINA GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 64. INDIA GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 65. INDIA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 66. INDIA GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 67. JAPAN GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 68. JAPAN GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 69. JAPAN GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 70. REST OF APAC GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 71. REST OF APAC GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) TABLE 72. REST OF APAC GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) TABLE 73. LATIN AMERICA GENOMICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION) TABLE 74. LATIN AMERICA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION) TABLE 75. LATIN AMERICA GENOMICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION) TABLE 76. BRAZIL GENOMICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION) TABLE 77. BRAZIL GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION) TABLE 78. BRAZIL GENOMICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION) TABLE 79. ARGENTINA GENOMICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION) TABLE 80. ARGENTINA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION) TABLE 81. ARGENTINA GENOMICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION) TABLE 82. MIDDLE EAST AND AFRICA GENOMICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION) TABLE 83. MIDDLE EAST AND AFRICA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION) TABLE 84. MIDDLE EAST AND AFRICA GENOMICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION) TABLE 85. SAUDI ARABIA GENOMICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION) TABLE 86. SAUDI ARABIA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION) TABLE 87. SAUDI ARABIA GENOMICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION) TABLE 88. UAE GENOMICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION) TABLE 89. UAE GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION) TABLE 90. UAE GENOMICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION) TABLE 91. REST OF MIDDLE EAST AND AFRICA GENOMICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION) TABLE 92. REST OF MIDDLE EAST AND AFRICA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION) TABLE 93. REST OF MIDDLE EAST AND AFRICA GENOMICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION) TABLE 94. CHART INDUSTRIES, INC.: FINANCIALS TABLE 95. CHART INDUSTRIES, INC.: PRODUCTS & SERVICES TABLE 96. CHART INDUSTRIES, INC.: RECENT DEVELOPMENTS TABLE 97. NIDEK MEDICAL PRODUCTS, INC: FINANCIALS TABLE 98. NIDEK MEDICAL PRODUCTS, INC: PRODUCTS & SERVICES TABLE 99. NIDEK MEDICAL PRODUCTS, INC: RECENT DEVELOPMENTS TABLE 100. BESCO MEDICAL CO. LTD: FINANCIALS TABLE 101. BESCO MEDICAL CO. LTD: PRODUCTS & SERVICES TABLE 102. BESCO MEDICAL CO. LTD: RECENT DEVELOPMENTS TABLE 103. KONINKLIJKE PHILIPS N.V: FINANCIALS TABLE 104. KONINKLIJKE PHILIPS N.V: PRODUCTS & SERVICES TABLE 105. KONINKLIJKE PHILIPS N.V: RECENT DEVELOPMENTS TABLE 106. DRIVE DEVILBISS HEALTHCARE LLC: FINANCIALS TABLE 107. DRIVE DEVILBISS HEALTHCARE LLC: PRODUCTS & SERVICES TABLE 108. DRIVE DEVILBISS HEALTHCARE LLC: RECENT DEVELOPMENTS TABLE 109. PRECISION MEDICAL, INC: FINANCIALS TABLE 110. PRECISION MEDICAL, INC: PRODUCTS & SERVICES TABLE 111. PRECISION MEDICAL, INC: RECENT DEVELOPMENTS TABLE 112. INVACARE CORPORATION: FINANCIALS TABLE 113. INVACARE CORPORATION: PRODUCTS & SERVICES TABLE 114. INVACARE CORPORATION: RECENT DEVELOPMENTS TABLE 115. AIRSEP CORPORATION: FINANCIALS TABLE 116. AIRSEP CORPORATION: PRODUCTS & SERVICES TABLE 117. AIRSEP CORPORATION: RECENT DEVELOPMENTS TABLE 118. PHILIPS HEALTHCARE: FINANCIALS TABLE 119. PHILIPS HEALTHCARE: PRODUCTS & SERVICES TABLE 120. PHILIPS HEALTHCARE: RECENT DEVELOPMENTS TABLE 121. O2 CONCEPTS, LLC: FINANCIALS TABLE 122. O2 CONCEPTS, LLC: PRODUCTS & SERVICES TABLE 123. O2 CONCEPTS, LLC: RECENT DEVELOPMENTS List of Charts CHART. 1. GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 2. GENOMICS MARKET VALUE FOR PRODUCT AND SERVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 3. GENOMICS MARKET VALUE FOR CONSUMABLES AND REAGENTS, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 4. GENOMICS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 5. GENOMICS MARKET VALUE FOR INSTRUMENTS,SYSTEMS AND SOFTWARE, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 6. GENOMICS MARKET VALUE, BY TECHNOLOGY, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 7. GENOMICS MARKET VALUE FOR SEQUENCING, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 8. GENOMICS MARKET VALUE FOR PCR, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 9. GENOMICS MARKET VALUE FOR FLOW CYTOMETRY, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 10. GENOMICS MARKET VALUE FOR MICROARRAYS, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 11. GENOMICS MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 12. GENOMICS MARKET VALUE FOR DRUG DISCOVERY AND DEVELOPMENT, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 13. GENOMICS MARKET VALUE FOR DIAGNOSTICS, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 14. GENOMICS MARKET VALUE FOR AGRICULTURE AND ANIMAL RESEARCH, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 15. GENOMICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 16. GENOMICS MARKET VALUE, BY STUDY TYPE, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 17. GENOMICS MARKET VALUE FOR FUNCTIONAL GENOMICS, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 18. GENOMICS MARKET VALUE FOR BIOMARKER DISCOVERY, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 19. GENOMICS MARKET VALUE FOR PATHWAY ANALYSIS, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 20. GENOMICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 21. GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 22. GENOMICS MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 23. GENOMICS MARKET VALUE FOR ACADEMICS AND RESEARCH INSTITUTE, BY GEOGRAPHY, 2021-2027 (USD BILLION) CHART. 24. NORTH AMERICA GENOMICS MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) CHART. 25. NORTH AMERICA GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 26. NORTH AMERICA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 27. NORTH AMERICA GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 28. U.S GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 29. U.S GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 30. U.S GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 31. CANADA GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 32. CANADA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 33. CANADA GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 34. EUROPE GENOMICS MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) CHART. 35. EUROPE GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 36. EUROPE GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 37. EUROPE GENOMICS MARKET VALUE, END-USER, 2021-2027 (USD BILLION) CHART. 38. GERMANY GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 39. GERMANY GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 40. GERMANY GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 41. U.K GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 42. U.K GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 43. U.K GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 44. FRANCE GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 45. FRANCE GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 46. FRANCE GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 47. ITALY GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 48. ITALY GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 49. ITALY GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 50. SPAIN GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 51. SPAIN GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 52. SPAIN GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 53. ROE GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 54. ROE GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 55. ROE GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 56. ASIA PACIFIC GENOMICS MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) CHART. 57. ASIA PACIFIC GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 58. ASIA PACIFIC GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 59. ASIA PACIFIC GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 60. CHINA GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 61. CHINA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 62. CHINA GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 63. INDIA GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 64. INDIA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 65. INDIA GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 66. JAPAN GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 67. JAPAN GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 68. JAPAN GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 69. REST OF APAC GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 70. REST OF APAC GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 71. REST OF APAC GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 72. LATIN AMERICA GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 73. LATIN AMERICA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 74. LATIN AMERICA GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 75. BRAZIL GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 76. BRAZIL GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 77. BRAZIL GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 78. ARGENTINA GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 79. ARGENTINA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 80. ARGENTINA GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 81. MIDDLE EAST AND AFRICA GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 82. MIDDLE EAST AND AFRICA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 83. MIDDLE EAST AND AFRICA GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 84. SAUDI ARABIA GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 85. SAUDI ARABIA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 86. SAUDI ARABIA GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 87. UAE GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 88. UAE GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 89. UAE GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION) CHART. 90. REST OF MIDDLE EAST AND AFRICA GENOMICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) CHART. 91. REST OF MIDDLE EAST AND AFRICA GENOMICS MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION) CHART. 92. REST OF MIDDLE EAST AND AFRICA GENOMICS MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
Publisher: IHR Insights
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support